These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6120059)

  • 21. Absolute bioavailability and effect of food and antacid on diazepam absorption from a slow-release preparation.
    Locniskar A; Greenblatt DJ; Zinny MA; Harmatz JS; Shader RI
    J Clin Pharmacol; 1984; 24(5-6):255-63. PubMed ID: 6747022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cimetidine interaction with dipotassium clorazepate disposition in the anesthetized dog.
    Colin P; Sirois G; Lelorier J
    Arch Int Pharmacodyn Ther; 1984 Mar; 268(1):12-24. PubMed ID: 6145392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the influence of antacids and H2 antagonists on the absorption of moxifloxacin after oral administration of a 400mg dose to healthy volunteers.
    Stass H; Böttcher MF; Ochmann K
    Clin Pharmacokinet; 2001; 40 Suppl 1():39-48. PubMed ID: 11352441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Rennie Liquid versus Maalox Liquid on intragastric pH in a double-blind, randomized, placebo-controlled, triple cross-over study in healthy volunteers.
    Hürlimann S; Michel K; Inauen W; Halter F
    Am J Gastroenterol; 1996 Jun; 91(6):1173-80. PubMed ID: 8651166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Steady-state bioavailability of two clorazepate dipotassium dosage forms.
    Carrigan PJ; Chao GC; Barker WM; Hoffman DJ; Chun AH
    J Clin Pharmacol; 1977 Jan; 17(1):18-28. PubMed ID: 13089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of an antacid containing aluminum and magnesium on the pharmacokinetics of cefixime.
    Healy DP; Sahai JV; Sterling LP; Racht EM
    Antimicrob Agents Chemother; 1989 Nov; 33(11):1994-7. PubMed ID: 2610509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of aluminum and magnesium antacids and ranitidine on the absorption of ciprofloxacin.
    Nix DE; Watson WA; Lener ME; Frost RW; Krol G; Goldstein H; Lettieri J; Schentag JJ
    Clin Pharmacol Ther; 1989 Dec; 46(6):700-5. PubMed ID: 2598571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antacid and formula effects on gastric acidity in infants with gastroesophageal reflux.
    Sutphen JL; Dillard VL; Pipan ME
    Pediatrics; 1986 Jul; 78(1):55-7. PubMed ID: 3725503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Intragastric utilization of antacids following meals in relation to stomach emptying].
    Lux G; Hartog C; Ruppin H; Lederer P; Schmitt W
    Z Gastroenterol; 1983 Mar; 21 Suppl():41-9. PubMed ID: 6858410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clorazepate kinetics in treated epileptics.
    Wilensky AJ; Levy RH; Troupin AS; Moretti-Ojemann L
    Clin Pharmacol Ther; 1978 Jul; 24(1):22-30. PubMed ID: 26493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of interaction between valaciclovir, the L-valyl ester of acyclovir, and Maalox antacid.
    de Bony F; Bidault R; Peck R; Posner J
    J Antimicrob Chemother; 1996 Feb; 37(2):383-7. PubMed ID: 8707752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prolongation of drug half-life due to obesity: studies of desmethyldiazepam (clorazepate).
    Abernethy DR; Greenblatt DJ; Divoll M; Shader RI
    J Pharm Sci; 1982 Aug; 71(8):942-4. PubMed ID: 6811726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Serum and urine electrolyte behavior under therapeutic dosage of a potent magnesium and aluminum hydroxide containing antacid].
    Grünzig G; Lücker PW; Schnitker J
    Arzneimittelforschung; 1983; 33(2):258-62. PubMed ID: 6682667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of metal-cation antacids on the pharmacokinetics of 1200 mg raltegravir.
    Krishna R; East L; Larson P; Valiathan C; Butterfield K; Teng Y; Hernandez-Illas M
    J Pharm Pharmacol; 2016 Nov; 68(11):1359-1365. PubMed ID: 27671833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of the antacid Maalox on the pharmacokinetics of capecitabine in cancer patients.
    Reigner B; Clive S; Cassidy J; Jodrell D; Schulz R; Goggin T; Banken L; Roos B; Utoh M; Mulligan T; Weidekamm E
    Cancer Chemother Pharmacol; 1999; 43(4):309-15. PubMed ID: 10071982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The choice of an antacid in therapy: use of in vivo methods].
    Caulin C; Isal JP
    Gastroenterol Clin Biol; 1983 Nov; 7(11):931. PubMed ID: 6653980
    [No Abstract]   [Full Text] [Related]  

  • 37. Lack of pharmacokinetic interaction between linezolid and antacid in healthy volunteers.
    Grunder G; Zysset-Aschmann Y; Vollenweider F; Maier T; Krähenbühl S; Drewe J
    Antimicrob Agents Chemother; 2006 Jan; 50(1):68-72. PubMed ID: 16377669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic model for diazepam and its major metabolite desmethyldiazepam following diazepam administration.
    Jack ML; Colburn WA
    J Pharm Sci; 1983 Nov; 72(11):1318-23. PubMed ID: 6417322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prolonged accumulation of diazepam in obesity.
    Abernethy DR; Greenblatt DJ; Divoll M; Shader RI
    J Clin Pharmacol; 1983; 23(8-9):369-76. PubMed ID: 6415130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Bioavailibility of dipotassium chlorazepate].
    Langenberg K; Staak M; Sticht G; Käferstein H
    Beitr Gerichtl Med; 1982; 40():329-34. PubMed ID: 6131664
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.